The AlphaLISA™ SureFire® Ultra™ Human Total ULK1 assay is a sandwich immunoassay for quantitative detection of total ULK1 in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 30 µL |
The AlphaLISA™ SureFire® Ultra™ Human Total ULK1 assay is a sandwich immunoassay for quantitative detection of total ULK1 in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
UNC-51 like autophagy activating kinase exists in two similar isoforms, ULK1 and ULK2. ULK1 is regulated by the key nutrient/energy-sensitive kinases mTOR and AMPK, which are both able to phosphorylate ULK1 and directly regulate its kinase activity. ULK1 forms a complex with the Atg13 and FIP200 proteins, this complex is the most upstream component of the core autophagy machinery and is, therefore, the key initiator of autophagy in mammalian cells. ULK1 is implicated in a variety of therapeutic areas including oncology, autoimmunity, neurology, and diabetes.
The AlphaLISA SureFire Human Total ULK1 Detection Kit is a sandwich immunoassay for the quantitative detection of total ULK1 in cellular lysates, using Alpha Technology.
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Lysis Buffer Compatibility |
Lysis Buffer
|
Molecular Modification |
Total
|
Product Group |
Kit
|
Sample Volume |
30 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
ULK1
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
Alpha
|
Therapeutic Area |
Autoimmunity
Immuno-oncology
Metabolic
Neuroscience
Oncology
|
Unit Size |
100 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Therapeutic antibodies directed to cell surface receptors are increasingly being developed as treatments for a variety of diseases...
The measurement of protein phosphorylation is a useful tool for measuring the modulation of receptor activation by both antibodies...
We are here to answer your questions.